Insider · CIK 0001224981

SLANSKY RICHARD B

Reports to the SEC for 5 companies · POWAY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001224981

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-30	GNTAGenenta Science S.p.A. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2018-07-05	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−6,725 sh	$1.31	−$8,823.2	270,016
2018-06-29	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−2,420 sh	$1.38	−$3,339.6	276,741
2018-06-28	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−3,532 sh	$1.40	−$4,948.332	279,161
2018-06-27	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−7,832 sh	$1.37	−$10.8K	282,693
2018-06-26	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−10.7K sh	$1.40	−$14.9K	290,525
2018-06-25	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−458 sh	$1.41	−$643.49	301,198
2018-06-22	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−6,710 sh	$1.42	−$9,514.78	301,656
2018-06-21	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−4,944 sh	$1.40	−$6,926.544	308,366
2018-06-20	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−24.9K sh	$1.42	−$35.4K	313,310
2018-06-19	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−4,171 sh	$1.36	−$5,689.244	338,216
2018-06-18	ONCOSEC MEDICAL IncS Sale	Chief Financial Officer	SSale	−12.6K sh	$1.39	−$17.5K	342,387
2018-06-15	ONCOSEC MEDICAL IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+100K sh	—	—	255,000
2018-06-15	ONCOSEC MEDICAL IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+100K sh	—	—	355,000
2018-06-15	ONCOSEC MEDICAL IncRestricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−100K sh	—	—	0
2018-06-15	ONCOSEC MEDICAL IncRestricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−100K sh	—	—	0
2018-05-03	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	$1.47	+$147K	447,500
2018-01-12	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	347,500
2017-03-29	ONCOSEC MEDICAL IncRestricted Stock UnitsA Award	Chief Financial Officer	AAward	+100K sh	—	—	200,000
2017-03-29	ONCOSEC MEDICAL IncOption to Purchase Common StockA Award	Chief Financial Officer	AAward	+75K sh	$1.34	+$101K	247,500
2016-12-14	ONCOSEC MEDICAL IncNon-qualified Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−150K sh	—	—	0
2016-12-14	ONCOSEC MEDICAL IncEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−75K sh	—	—	0
2016-12-14	ONCOSEC MEDICAL IncEmployee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+113K sh	—	—	112,500
2016-03-04	ONCOSEC MEDICAL IncOption to Purchase Common StockA Award	Chief Financial Officer	AAward	+60K sh	$2.02	+$121K	285,000
2016-03-04	ONCOSEC MEDICAL IncRestricted Stock UnitsA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2015-08-20	ONCOSEC MEDICAL IncOption to Purchase Common StockA Award	Chief Financial Officer	AAward	+75K sh	$5.67	+$425K	75,000
2015-07-06	ONCOSEC MEDICAL IncP Purchase	Chief Financial Officer	PPurchase	+150K sh	$6.12	+$918K	150,000
2014-03-11	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−1,680 sh	$12.17	−$20.4K	81,836
2014-03-06	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+16.9K sh	—	—	83,516
2014-03-06	GenMark Diagnostics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2014-02-07	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−838 sh	$12.29	−$10.3K	66,579
2013-11-06	GenMark Diagnostics, Inc.S Sale	Chief Financial Officer	SSale	−660 sh	$11.72	−$7,735.2	66,359
2013-05-06	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+15K sh	—	—	67,019
2013-03-06	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+21.6K sh	—	—	52,019
2013-03-06	GenMark Diagnostics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+23K sh	—	—	23,000
2012-06-26	GenMark Diagnostics, Inc.P Purchase	Chief Financial Officer	PPurchase	+25K sh	$4.20	+$105K	55,395
2012-05-30	GenMark Diagnostics, Inc.A Award	Chief Financial Officer	AAward	+30.4K sh	—	—	30,395
2012-05-04	GenMark Diagnostics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+76.8K sh	—	—	76,849
2012-05-04	GenMark Diagnostics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+76.8K sh	—	—	76,849
2012-04-10	STAR OPERATING COMPANIES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,732 sh	—	—	31,771
2012-04-10	STAR OPERATING COMPANIES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,732 sh	$2.05	−$5,591.584	29,039
2012-04-10	STAR OPERATING COMPANIES, INC.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,125 sh	—	—	1,125
2012-04-10	STAR OPERATING COMPANIES, INC.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,607 sh	—	—	1,607
2012-04-10	STAR OPERATING COMPANIES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,732 sh	—	—	31,771
2012-04-10	STAR OPERATING COMPANIES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,732 sh	$2.05	−$5,591.584	29,039
2012-04-10	STAR OPERATING COMPANIES, INC.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,125 sh	—	—	1,125
2012-04-10	STAR OPERATING COMPANIES, INC.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,607 sh	—	—	1,607
2012-01-17	STAR OPERATING COMPANIES, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,954 sh	—	—	27,641
2012-01-17	STAR OPERATING COMPANIES, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,954 sh	$1.94	−$5,731.055	24,687
2012-01-17	STAR OPERATING COMPANIES, INC.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,216 sh	—	—	1,216

Recent filings

Accepted (ET)
Apr 14
SLANSKY RICHARD B0001493152-26-014629
SEC(opens sec.gov)
Jul 64
SLANSKY RICHARD B0001493152-18-009768
SEC(opens sec.gov)
May 74
SLANSKY RICHARD B0001493152-18-006354
SEC(opens sec.gov)
Jan 174
SLANSKY RICHARD B0001493152-18-000655
SEC(opens sec.gov)
Mar 314
ONCOSEC MEDICAL Inc0001493152-17-003332
SEC(opens sec.gov)

Companies

Address

13973 CARRIAGE ROAD

POWAY, CA, 92064